Supply of tofacitinib tablets
Open · 10 days left Hong Kong SAR, China · Medicines
| Buyer | Hospital Authority, Hong Kong |
|---|---|
| Reference | HAHO(S)/T/26-D084 |
| Published | 16 September 2026 |
| Closing date | 30 October 2026, 12:00 noon Hong Kong time (GMT+8) |
| Products | Tofacitinib (citrate) tablets. Initial term up to 36 months, with up to 24 months' extension. Quantities in Appendix 1. |
| Notes | Product must be registered in Hong Kong; patent or freedom-to-operate evidence may be needed for non-innovator versions. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in Hong Kong SAR, China
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Supply of linezolid 600 mg injection (Hong Kong SAR, China, 2 Nov)
- Supply of lapatinib 250 mg tablets (Hong Kong SAR, China, 11 Nov)
- Supply of mercaptopurine 50 mg tablets (Hong Kong SAR, China, 13 Nov)
- Medicines invitation Med 9/2026/D (shortage medicines) (Iraq, 25 Oct)
- Supply of adult antiretroviral (ARV) medicines, lot I (Global Fund GC7) (Kenya, 27 Oct)
- Supply of paediatric antiretroviral (ARV) medicines (Global Fund GC7) (Kenya, 27 Oct)
